AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1325880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with doxazosin and enalapril
Number of subjects: 15
Study 6742335 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and Jaboulay pyloroplasty (Group 1)
Number of subjects: 67
Study 6742335 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietal cell vagotomy and Jaboulay pyloroplasty (Group 2)
Number of subjects: 67
Study 6742335 — intervention group
Group type: COMPARATOR
Intervention: Parietal cell vagotomy without drainage (Group 3)
Number of subjects: 67
Study 30851536 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature Infant Oral Motor Intervention (PIOMI) administered over 10 days.
Number of subjects: 30
Study 30851536 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing services (Control group).
Number of subjects: 30
Study 30851536 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight measurements over time for intervention group.
Number of subjects: 30
Study 30851536 — intervention group
Group type: COMPARATOR
Intervention: Weight measurements over time for control group.
Number of subjects: 30
Study 29214740 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 μg) plus intravitreal antibiotics (0.2 mg vancomycin and 0.05 mg gentamicin)
Number of subjects: 167
Study 29214740 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus intravitreal antibiotics (0.2 mg vancomycin and 0.05 mg gentamicin)
Number of subjects: 167
Study 29214740 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 μg) plus intravitreal antibiotics
Number of subjects: 167
Study 29214740 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus intravitreal antibiotics
Number of subjects: 167
Study 26768146 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug Eluting Balloon (DCB)
Number of subjects: 64
Study 26768146 — intervention group
Group type: COMPARATOR
Intervention: Plain Old Balloon Angioplasty (POBA)
Number of subjects: 64
Study 27041697 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical orthodontic treatment before secondary alveolar bone grafting (SABG)
Number of subjects: 24
Study 27041697 — intervention group
Group type: COMPARATOR
Intervention: Conventional SABG alone (without presurgical orthodontic treatment)
Number of subjects: 24
Study 22744733 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service (SMS) questionnaire, n = 171
Number of subjects: 564
Study 22744733 — intervention group
Group type: COMPARATOR
Intervention: Web questionnaire, n = 182
Number of subjects: 564
Study 22744733 — intervention group
Group type: COMPARATOR
Intervention: Paper questionnaire, n = 211
Number of subjects: 564
Study 20405117 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 80 ppm inhaled nitric oxide (iNO) and 100% oxygen (O(2))
Number of subjects: 0
Study 20405117 — intervention group
Group type: COMPARATOR
Intervention: O(2) alone
Number of subjects: 0
Study 18315511 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp acupuncture (scalp AP) sessions twice weekly for 9 months in group B, alongside language therapy (LT).
Number of subjects: 20
Study 18315511 — intervention group
Group type: COMPARATOR
Intervention: Language therapy (LT) twice weekly for 9 months in both groups.
Number of subjects: 20
Study 15999468 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced blood and/or blood product transfusion (BBPT)
Number of subjects: 69
Study 15999468 — intervention group
Group type: COMPARATOR
Intervention: Control group (unfiltered BBPT)
Number of subjects: 69
Study 15999468 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukoreduced BBPT
Number of subjects: 69
Study 12423324 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg in the evening)
Number of subjects: 30
Study 12423324 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (2500 Lux for 1 h in the morning)
Number of subjects: 30
Study 12423324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10066203 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose rivastigmine (6-12 mg/day)
Number of subjects: 725
Study 10066203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 725
Study 10066203 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose rivastigmine (1-4 mg/day)
Number of subjects: 725
Study 7783097 — intervention group
Group type: EXPERIMENTAL
Intervention: Omron HEM403C
Number of subjects: 212
Study 1914054 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alfentanil (35.1 micrograms.kg‐1 then continuous infusion of 16.2 micrograms.kg‐1.hr‐1)
Number of subjects: 33
Study 1914054 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-dose alfentanil (70.2 micrograms.kg‐1 then continuous infusion of 32.4 micrograms.kg‐1.hr‐1)
Number of subjects: 33
Study 1914054 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alfentanil (105.3 micrograms.kg‐1 then continuous infusion of 48.6 micrograms.kg‐1.hr‐1)
Number of subjects: 33
Study 1914054 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (8.3 micrograms.kg‐1 then continuous infusion of 1.6 micrograms.kg‐1.hr‐1)
Number of subjects: 33
Study 6307933 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectin (36 g/d for 3 weeks)
Number of subjects: 11
Study 6307933 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown and wholemeal breads (3 weeks each)
Number of subjects: 11
Study 6307933 — intervention group
Group type: COMPARATOR
Intervention: White bread (3 weeks)
Number of subjects: 11
Study 31822548 — intervention group
Group type: COMPARATOR
Intervention: Cemented hemiarthroplasty
Number of subjects: 1128
Study 31822548 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite coated uncemented hemiarthroplasty
Number of subjects: 1128
Study 29298102 — intervention group
Group type: EXPERIMENTAL
Intervention: Deer Bone Extract (DBE) 550 mg/day for 12 weeks
Number of subjects: 50
Study 29298102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 26792619 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic therapy (pool exercises) starting 6 days after surgery
Number of subjects: 827
Study 26792619 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergometer cycling starting 2 weeks after surgery
Number of subjects: 827
Study 26792619 — intervention group
Group type: COMPARATOR
Intervention: Nonergometer group (control)
Number of subjects: 827
Study 26792619 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of aquatic therapy
Number of subjects: 827
Study 25107542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (400 micrograms)
Number of subjects: 81
Study 25107542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 25107542 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study 21841518 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination paste (morphine + methylprednisolone)
Number of subjects: 201
Study 21841518 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid paste (methylprednisolone alone)
Number of subjects: 201
Study 21841518 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine paste (morphine alone)
Number of subjects: 201
Study 19260867 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 3441
Study 19260867 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity measures (BMI, waist circumference, waist-to-hip ratio)
Number of subjects: 3441
Study 21035949 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation retreat participants
Number of subjects: 30
Study 21035949 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study 16049250 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroflow device and LMWH
Number of subjects: 227
Study 16049250 — intervention group
Group type: COMPARATOR
Intervention: LMWH only
Number of subjects: 227
Study 12081672 — intervention group
Group type: EXPERIMENTAL
Intervention: Microprocessor-controlled local anesthesia (Wand)
Number of subjects: 101
Study 12081672 — intervention group
Group type: COMPARATOR
Intervention: Traditional injection technique
Number of subjects: 101
Study 10638393 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous N-acetylcysteine infusion (3.4-4.6 mg/kg/h for 24 hours in study I; 0.3-1.3 mg/kg/h for 6 days in study II)
Number of subjects: 16
Study 7499080 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (50,000 IU for neonates, 100,000 IU for 1-11 month-olds, 200,000 IU for 1-4 year-olds)
Number of subjects: 4766
Study 7499080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4766
Study 7499080 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 4766
Study 1911318 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral indomethacin
Number of subjects: 50
Study 1911318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7022295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 104
Study 7022295 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose CMF (cyclophosphamide, methotrexate, and 5-fluorouracil)
Number of subjects: 104
Study 29454763 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 894
Study 29454763 — intervention group
Group type: COMPARATOR
Intervention: Biolimus-eluting stent (BES)
Number of subjects: 894
Study 29454763 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-guided implantation
Number of subjects: 894
Study 29454763 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided implantation
Number of subjects: 894
Study 29454763 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month DAPT
Number of subjects: 894
Study 29454763 — intervention group
Group type: COMPARATOR
Intervention: 12-month DAPT
Number of subjects: 894
Study 27443226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins (NLRP1, ASC, caspase‐1) in SAH patients
Number of subjects: 34
Study 27443226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins in SAH patients with cerebral edema
Number of subjects: 34
Study 27443226 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) inflammasome proteins in SAH patients with acute hydrocephalus
Number of subjects: 34
Study 27443226 — intervention group
Group type: EXPERIMENTAL
Intervention: High level of NLRP1 in SAH patients
Number of subjects: 34
Study 24026563 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 87
Study 24026563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint reminiscence groups held weekly for 12 consecutive weeks, followed by monthly maintenance sessions for a further 7 months.
Number of subjects: 488
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint reminiscence groups for people with dementia and their caregivers.
Number of subjects: 488
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint reminiscence groups for people with dementia who attended more sessions.
Number of subjects: 488
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint reminiscence groups for caregivers who attended more groups.
Number of subjects: 488
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Health and social care services usage.
Number of subjects: 488
Study 23211271 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-adjusted life-year gains derived from European Quality of Life-5 Dimensions.
Number of subjects: 488
Study 20573384 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral intrafascial nsEERPE (group A)
Number of subjects: 400
Study 20573384 — intervention group
Group type: COMPARATOR
Intervention: Bilateral standard nsEERPE (group B)
Number of subjects: 400
Study 19014075 — intervention group
Group type: EXPERIMENTAL
Intervention: Real CPAP
Number of subjects: 102
Study 19014075 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 102
Study 15834098 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg oral moxifloxacin (two doses with a 12 hour interval)
Number of subjects: 35
Study 12653425 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week, low-calorie diet
Number of subjects: 82
Study 12653425 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 82
Study 10566928 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) with cuff volumes ranging from 0 to 40 ml
Number of subjects: 20
Study 10566928 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA) with cuff volumes ranging from 0 to 60 ml
Number of subjects: 20
Study 10566928 — intervention group
Group type: COMPARATOR
Intervention: No airway device (controls)
Number of subjects: 20
Study 8946925 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (alloBMT)
Number of subjects: 204
Study 8946925 — intervention group
Group type: COMPARATOR
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 204
Study 8946925 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (Chemo)
Number of subjects: 204
Study 8946925 — intervention group
Group type: COMPARATOR
Intervention: ASCT
Number of subjects: 204
Study 8946925 — intervention group
Group type: COMPARATOR
Intervention: Chemo
Number of subjects: 204
Study 1768574 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan, given at molar concentrations below those required to stimulate duodenal osmoreceptors.
Number of subjects: 0
Study 1768574 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine, given in concentrations similar to those of levodopa.
Number of subjects: 0
Study 1768574 — intervention group
Group type: COMPARATOR
Intervention: Levodopa, concentrations not specified.
Number of subjects: 0
Study 7032340 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigen-free elemental diet (Vivasorb)
Number of subjects: 41
Study 7032340 — intervention group
Group type: COMPARATOR
Intervention: Control diet (blended ordinary hospital food)
Number of subjects: 41
Study 29697464 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin/Fosphenytoin
Number of subjects: 1916
Study 29697464 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 1916
Study 29697464 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin/Fosphenytoin vs Levetiracetam
Number of subjects: 1916
Study 29697464 — intervention group
Group type: COMPARATOR
Intervention: Seizure history
Number of subjects: 1916
Study 29697464 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis of brain tumor
Number of subjects: 1916
Study 29697464 — intervention group
Group type: COMPARATOR
Intervention: Temporal craniotomy
Number of subjects: 1916
Study 29874680 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 40
Study 29874680 — intervention group
Group type: COMPARATOR
Intervention: Relaxation group
Number of subjects: 40
Study 27502803 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) in addition to neurodevelopmental therapy (NDT)
Number of subjects: 75
Study 27502803 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) in addition to neurodevelopmental therapy (NDT)
Number of subjects: 75
Study 27502803 — intervention group
Group type: COMPARATOR
Intervention: Control group (NDT only)
Number of subjects: 75
Study 24821594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrazinamide MIC ≤ 50 mg/L
Number of subjects: 58
Study 24821594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrazinamide MIC > 50 mg/L
Number of subjects: 58
Study 24821594 — intervention group
Group type: COMPARATOR
Intervention: Standard combination therapy (isoniazid, rifampicin, pyrazinamide, ethambutol)
Number of subjects: 58
Study 22968617 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush
Number of subjects: 0
Study 22968617 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 0
Study 20692169 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tuberculosis treatment (ATT)
Number of subjects: 25
Study 20692169 — intervention group
Group type: COMPARATOR
Intervention: Current standard therapies (Control)
Number of subjects: 25
Study 17464305 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 degrees total capsule cover (group I)
Number of subjects: 150
Study 17464305 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial cover (group II)
Number of subjects: 150
Study 17464305 — intervention group
Group type: COMPARATOR
Intervention: No cover (group III)
Number of subjects: 150
Study 17464305 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups I and II
Number of subjects: 150
Study 17464305 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I vs group II
Number of subjects: 150
Study 17464305 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartile change in area of capsule cover
Number of subjects: 150
Study 15849647 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports medicine class
Number of subjects: 150
Study 15849647 — intervention group
Group type: COMPARATOR
Intervention: Control group (students not participating in the sports medicine class)
Number of subjects: 150
Study 12500711 — intervention group
Group type: EXPERIMENTAL
Intervention: phenytoin
Number of subjects: 256
Study 12500711 — intervention group
Group type: COMPARATOR
Intervention: fosphenytoin
Number of subjects: 256
Study 9708514 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mCi/4 ml unfiltered 99mTc‐sulfur colloid injected in four divided doses around the palpable lesion or adjacent to the excision cavity
Number of subjects: 32
Study 7860458 — intervention group
Group type: EXPERIMENTAL
Intervention: High father involvement (n = 305)
Number of subjects: 985
Study 7860458 — intervention group
Group type: COMPARATOR
Intervention: Low father involvement (n = 148)
Number of subjects: 985
Study 2612167 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms 3kDOG per 24 hours (Group A)
Number of subjects: 20
Study 2612167 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 micrograms 3kDOG per 24 hours (Group B)
Number of subjects: 20
Study 2612167 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 20
Study 341904 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopredone acetate 0.01%
Number of subjects: 0
Study 341904 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopredone acetate 0.025%
Number of subjects: 0
Study 341904 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopredone acetate 0.05%
Number of subjects: 0
Study 341904 — intervention group
Group type: EXPERIMENTAL
Intervention: Halopredone acetate (all concentrations)
Number of subjects: 0
Study 30861334 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) + Methotrexate (MTX)
Number of subjects: 75
Study 30861334 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide (LEF) + Methotrexate (MTX)
Number of subjects: 75
Study 28902703 — intervention group
Group type: EXPERIMENTAL
Intervention: Attending school (≥80% school days)
Number of subjects: 0
Study 28902703 — intervention group
Group type: EXPERIMENTAL
Intervention: Dropping out of school
Number of subjects: 0
Study 26563923 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesic (MMA) injection with morphine, ropivacaine, and methylprednisolone
Number of subjects: 50
Study 26563923 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (Control)
Number of subjects: 50
Study 26563923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 23510018 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to the highest approved dose of rosuvastatin (40 mg)
Number of subjects: 100
Study 23510018 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on extended release nicotinic acid (ER-NA)/l-aropiprant (LRPT)
Number of subjects: 100
Study 23510018 — intervention group
Group type: COMPARATOR
Intervention: Add-on micronised fenofibrate
Number of subjects: 100
Study 20706728 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil capsules (11 g/day)
Number of subjects: 59
Study 20706728 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (2 g/day + 9 g/day of olive oil)
Number of subjects: 59
Study 20706728 — intervention group
Group type: COMPARATOR
Intervention: Olive oil capsules (11 g/day)
Number of subjects: 59
Study 20706728 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 59
Study 19936516 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Lippia Sidoides (LS) gel
Number of subjects: 23
Study 19936516 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (control group)
Number of subjects: 23
Study 17963876 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS examination
Number of subjects: 206
Study 15272397 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC‐HIV (vCP1521) and AIDSVAX B/E
Number of subjects: 133
Study 15272397 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDSVAX B/E (600 microg)
Number of subjects: 133
Study 11299133 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 100mg per day for 2 weeks
Number of subjects: 11
Study 11299133 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 11
Study 9882034 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical treatment with omeprazole
Number of subjects: 80
Study 9882034 — intervention group
Group type: COMPARATOR
Intervention: Prompt endoscopy followed by directed medical treatment
Number of subjects: 80
Study 7912879 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine + dixyrazine
Number of subjects: 45
Study 7912879 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine + placebo
Number of subjects: 45
Study 2803882 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine with fentanyl (loading dose of 0.5% bupivacaine 6.0 ml and fentanyl 100 micrograms, followed by infusion of 0.08% bupivacaine 15 ml h‐1 plus fentanyl 37.5 micrograms h‐1)
Number of subjects: 39
Study 2803882 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine alone (loading dose of 0.5% bupivacaine 6.0 ml and saline 2.0 ml, followed by infusion of 0.08% bupivacaine alone)
Number of subjects: 39
Study 4827462 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg/70 kg heroin
Number of subjects: 10